Medicure (MCUJF) Common Equity (2009 - 2026)

Medicure's Common Equity history runs 18 years deep, the most recent figure standing at $9.2 million for Q1 2026.

• In Q1 2026, Common Equity fell 34.15% year-over-year to $9.2 million; the TTM figure through Mar 2026 stood at $9.2 million (down 34.15% YoY), while the FY2025 annual figure was $9.3 million, down 37.76% from the prior year.
• Common Equity was $9.2 million for Q1 2026 at Medicure, roughly flat from $9.3 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $16.3 million in Q3 2023 to a low of $9.2 million in Q1 2026.
• Historically, Common Equity has averaged $14.1 million across 5 years, with a median of $14.6 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Common Equity grew 18.66% in 2022, then sank 37.76% in 2025.
• A 5-year view of Common Equity shows it stood at $15.5 million in 2022, then retreated by 5.56% to $14.6 million in 2023, then advanced by 1.78% to $14.9 million in 2024, then tumbled by 37.76% to $9.3 million in 2025, then slipped by 0.37% to $9.2 million in 2026.
• The last three Common Equity figures came in at $9.2 million (Q1 2026), $9.3 million (Q4 2025), and $12.6 million (Q3 2025), per Business Quant data.